AMBER BULLARD: Open Payments
NPI 1023694163 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$751 in 47 payments from 13 companies in 2025. Trend: 2023 $21 · 2024 $170 · 2025 $751
Food & beverage: $751
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $199 |
| PFIZER INC. | 7 | $185 |
| AstraZeneca Pharmaceuticals LP | 7 | $150 |
| Lundbeck LLC | 3 | $60 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| Verity Pharmaceuticals Inc. | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Exact Sciences Corporation | 1 | $16 |
| Antares Pharma, Inc. | 1 | $16 |
Products named: VRAYLAR, FARXIGA, NURTEC ODT, ZAVZPRET, REXULTI, QULIPTA, BREZTRI, UBRELVY.
Industry payments across SC — which companies pay providers there.
